WallStreetZenWallStreetZen

NASDAQ: CDXS
Codexis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CDXS

Based on 2 analysts offering 12 month price targets for Codexis Inc.
Min Forecast
$9.00+214.69%
Avg Forecast
$9.50+232.17%
Max Forecast
$10.00+249.65%

Should I buy or sell CDXS stock?

Based on 2 analysts offering ratings for Codexis Inc.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CDXS stock forecasts and price targets.

CDXS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-29
lockedlocked$00.00+00.00%2023-11-06

1 of 1

Forecast return on equity

Is CDXS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is CDXS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CDXS revenue forecast

What is CDXS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$67.4M-3.91%
Avg 2 year Forecast
$63.9M-8.93%
Avg 3 year Forecast
$102.1M+45.56%
CDXS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDXS revenue growth forecast

How is CDXS forecast to perform vs Biotechnology companies and vs the US market?
Company
6%
Industry
37.64%
Market
10.1%
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDXS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDXS$2.86$9.50+232.17%Strong Buy
ABEO$7.36N/AN/A
NBTX$5.73$11.00+91.97%Buy
TRVI$2.94$8.50+189.12%Buy
ZVRA$4.57$15.00+228.23%Buy
View Top Biotech Stocks

Codexis Stock Forecast FAQ

Is Codexis Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDXS) stock is to Strong Buy CDXS stock.

Out of 2 analysts, 2 (100%) are recommending CDXS as a Strong Buy, 0 (0%) are recommending CDXS as a Buy, 0 (0%) are recommending CDXS as a Hold, 0 (0%) are recommending CDXS as a Sell, and 0 (0%) are recommending CDXS as a Strong Sell.

If you're new to stock investing, here's how to buy Codexis stock.

What is CDXS's revenue growth forecast for 2024-2026?

(NASDAQ: CDXS) Codexis's forecast annual revenue growth rate of 6% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

Codexis's revenue in 2024 is $70,143,000.On average, 4 Wall Street analysts forecast CDXS's revenue for 2024 to be $4,738,465,269, with the lowest CDXS revenue forecast at $4,218,218,340, and the highest CDXS revenue forecast at $4,991,558,369. On average, 4 Wall Street analysts forecast CDXS's revenue for 2025 to be $4,490,785,548, with the lowest CDXS revenue forecast at $3,585,485,589, and the highest CDXS revenue forecast at $5,097,013,828.

In 2026, CDXS is forecast to generate $7,178,001,542 in revenue, with the lowest revenue forecast at $7,178,001,542 and the highest revenue forecast at $7,178,001,542.

What is CDXS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CDXS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CDXS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDXS price target, the average CDXS price target is $9.50, with the highest CDXS stock price forecast at $10.00 and the lowest CDXS stock price forecast at $9.00.

On average, Wall Street analysts predict that Codexis's share price could reach $9.50 by Feb 28, 2025. The average Codexis stock price prediction forecasts a potential upside of 232.17% from the current CDXS share price of $2.86.

What is CDXS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CDXS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.